ABSTRACT 11Beta-hydroxysteroid dehydrogenase (HSD11B) enzymes have important roles in regulating cortisol availability in target tissues. We previously demonstrated that HSD11B1 is expressed and active in bovine endometrium and that cortisol suppresses prostaglandin (PG) F2alpha and PGE2 production in cultured bovine endometrial stromal cells. The present study was conducted to examine whether locally synthesized PGF2alpha and/or PGE2 regulates the enzymatic bioactivity and/or the expression of HSD11B1 in bovine endometrium. The conversion rate of cortisone to cortisol in cultured endometrial stromal cells was significantly stimulated by PGF2alpha (1 and 10 lM). In a dose-dependent manner, PGF2alpha but not PGE2 increased the net conversion of cortisone to cortisol in stromal cells after 4 h of treatment. In addition, the bioactivity of HSD11B1 was significantly inhibited by indomethacin (10 lM). The inhibitory effect of indomethacin on HSD11B1 bioactivity was abolished by PGF2alpha (1 lM) but not by PGE2. Although PGF2alpha (1 lM) did not affect the expression of HSD11B1 mRNA in cultured stromal cells, it significantly stimulated the protein expression of HSD11B1. Cycloheximide, a general translational inhibitor, abolished the stimulatory effects of PGF2alpha on HSD11B1 protein expression in endometrial stromal cells, indicating that PGF2alpha increases HSD11B1 protein expression by stimulating a posttranscriptional process rather than a transcriptional mechanism. These results demonstrate that PGF2alpha but not PGE2 increases HSD11B1 bioactivity and protein expression by stimulating a posttranscriptional mechanism in stromal cells and suggest that cortisol has a physiologically relevant role in preventing excessive uterine PG production in nonpregnant bovine endometrium.
INTRODUCTION
Glucocorticoids (GCs) are involved in female reproductive functions [1, 2] . Glucocorticoid is produced by the adrenal cortex under the regulatory influence of adrenocorticotropic hormone. Because the action of GC on target cells depends on the binding of biologically active cortisol to the GC receptor (NR3C1), the local concentration of free cortisol in target cells is an important factor to determine the magnitude of GC action [3] . The access of GC to NR3C1 in target tissues is regulated by two 11b-hydroxysteroid dehydrogenases (HSD11Bs), namely, bidirectional HSD11B type 1 (HSD11B1), which mainly converts cortisone to active cortisol [4] , and dehydrogenase HSD11B type 2 (HSD11B2), which inactivates cortisol to cortisone [5, 6] . We recently demonstrated that bovine endometrium, especially endometrial stromal cells, are a target for GC and that endometrial tissue has the capacity to convert inactive cortisone to biologically active cortisol. Furthermore, HSD11B1 mRNA is highly expressed in the endometrium during the follicular phase and estrus in cattle. Moreover, the bioactivity of HSD11B1 also increased in the follicular phase [7] . The increase in HSD11B1 mRNA and bioactivity was temporally coincident with an increase in the basal release of prostaglandin (PG) F2a during the estrous cycle [7] [8] [9] . Based on these findings, we hypothesized that PGF2a produced by the endometrium locally enhances HSD11B1 enzyme bioactivity and/or protein expression in endometrial stromal cells to increase the local formation of cortisol from cortisone.
Prostaglandins are important regulators of reproductive events, including ovulation, implantation, parturition, luteolysis, and recognition of pregnancy [10, 11] . PGF2a has been demonstrated to potentiate the production of biologically active cortisol by stimulating HSD11B1 in human endometrium and fetal membranes during late gestation and labor [12, 13] . In contrast, we recently demonstrated in nonpregnant bovine endometrium that cortisol suppresses basal PGF2a production and tumor necrosis (TNF) a-stimulated PGF2a production in endometrial stromal cells but not in epithelial cells [7] . The inhibitory effect of cortisol on PGF2a production in bovine endometrial stromal cells [7] , as well as the stimulatory effect of GC on intrauterine PGs in pregnant ewes [14] and human placental membrane [15, 16] , suggests the presence of a dynamic interaction between PGs and GC in the uterus depending on the reproductive status. Although PGF2a has the ability to increase cortisol production by stimulating HSD11B1 in human ovarian surface epithelial cells [17] and in chorion trophoblast [12, 18] , the mechanisms by which PGF2a increases the biological action of HSD11B1 in bovine endometrium are poorly understood.
The present study was conducted to examine the role of locally synthesized PGF2a in regulating the enzymatic bioactivity and/or expression of HSD11B1 in bovine endometrial stromal cells. In addition, we investigated whether PGF2a affects HSD11B1 expression at the transcriptional or posttranscriptional level.
MATERIALS AND METHODS

Isolation of Endometrial Cells
Uteri of Holstein cows were obtained from a local abattoir in accord with protocols approved by the local institutional animal care and use committee. Estrus was synchronized using implants of a progesterone analogue (Crestar; Intervet, Boxmeer, the Netherlands) with additional injection of a PGF2a analogue (cloprostenol [Bioestrophan] ; Biowet, Gorzow Wielkopowski, Poland) as recommended by the manufacturer for the estrous synchronization of multiparous cows [19] . In this study, uteri of the early luteal phase (Days 2-5) were used. Uteri were obtained within 30 min after exsanguination and were transported to the laboratory within 1-1.5 h on ice. The epithelial and stromal cells from bovine endometrium were enzymatically separated (0.05% collagenase, No. C0130; Sigma Aldrich, St. Louis, MO) using procedures described previously [7] . A polyvinyl catheter was inserted into the side of the oviduct, and the ends of the horn were tied to retain trypsin solution for detaching the epithelial cells as described herein. The uterine lumen was washed three times with 30-50 ml of sterile Ca 2þ -free and Mg 2þ -free Hanks balanced salt solution (HBSS) supplemented with 100 IU/ml of penicillin, 100 lg/ml of streptomycin, and 0.1% (w/v) bovine serum albumin (BSA) (Roche Diagnostics, Indianapolis, IN). Thirty to fifty milliliters of sterile HBSS containing 0.3% (w/v) trypsin (Sigma Aldrich) was then infused into the uterine lumen through the catheter.
After collection of the epithelial cells, the uterine lumen was washed with sterile HBSS supplemented with antibiotics and 0.1% (w/v) BSA. The horn was then cut transversely using scissors into several segments, which were slit to expose the endometrial surface. Intercaruncular endometrial strips were dissected from the myometrial layer using a scalpel and washed once in 50 ml of sterile HBSS containing antibiotics. The endometrial strips were then minced into small pieces (1 mm 3 ). The minced tissues (; 5 g) were digested by stirring for 60 min in 50 ml of sterile HBSS containing 0.05% (w/v) collagenase (Sigma Aldrich), 0.005% (w/v) DNase I (Sigma Aldrich), and 0.1% (w/v) BSA. The dissociated cells were filtered through metal meshes (100 lm and 80 lm) to remove undissociated tissue fragments. The filtrate was washed three times by centrifugation (10 min at 100 3 g) with Dulbecco modified Eagle medium (DMEM) (Sigma Aldrich) supplemented with antibiotics and 0.1% (w/v) BSA. After the washes, the cells were counted using a hemocytometer. The cell viability was greater than 85% as assessed by 0.5% (w/v) trypan blue dye exclusion.
Culture of Endometrial Stromal Cells
The final pellet of the isolated stromal cells was resuspended in culture medium (DMEM/Ham F-12, 1:1 (v/v); Sigma Aldrich) supplemented with 10% (v/v) calf serum (Sigma Aldrich), 20 lg/ml of gentamicin (Invitrogen, San Diego, CA), and 2 lg/ml of amphotericin B (Sigma Aldrich) [20] . The stromal cells were seeded at a density of 1 3 10 5 viable cells/ml in 48-well cluster dishes (Greiner Bio-One, Monroe, NC) for experiments 1 and 2 and in 24-well cluster dishes (Costar, Cambridge, MA) or in 80-cm 2 culture flasks (Greiner Bio-One) for experiments 3 and 4 and were cultured at 37.58C in a humidified atmosphere of 5% CO 2 in air. For the stromal preparation, the medium was changed 2 h after plating, by which time selective attachment of stromal cells had occurred [20, 21] . The homogeneity of stromal cells was evaluated using immunofluorescent staining for specific markers of epithelial (cytokeratin) and stromal (vimentin) cells as described previously [22] . Epithelial cell contamination of stromal cells was about 1%. When cells were confluent (6-7 days after the start of the culture), the medium was replaced with fresh DMEM/Ham F-12 supplemented with 0.1% (w/v) BSA, 5 ng/ml of sodium selenite (Sigma Aldrich), 0.5 mM ascorbic acid (Wako Pure Chemical Industries, Ltd., Osaka, Japan), 5 mg/ml of transferrin (Sigma Aldrich), 2 mg/ ml of insulin (Sigma Aldrich), and 20 mg/ml of gentamicin.
Preliminary Experiment: Spontaneous PGF2a and PGE2 Release
After incubation for 0, 0.5, 1, 4, 12, and 24 h, 500 ll of conditioned media was collected. It was frozen at À308C until the PGF2a and PGE2 assays (n ¼ 3).
Experiment 1: Dose-and Time-Dependent Effects of PGF2a and PGE2 on HSD11B1 Bioactivity
To study the dose-dependent effects of PGF2a and PGE2 on HSD11B1 bioactivity, the level of HSD11B reductase bioactivity of cultured endometrial stromal cells was determined by measuring the net conversion rate from cortisone to cortisol as described previously [7] . Stromal cells were exposed to PGF2a (10 nM to 10 lM) for 0, 0.5, 1, 4, 12, and 24 h in the presence of cortisone (30 nM) (n ¼ 4). Furthermore, stromal cells were exposed to PGE2 (100 nM to 10 lM) for 4 h and 24 h in the presence of cortisone (30 nM) (n ¼ 3). At the end of incubation, 500 ll of conditioned media was collected and frozen at À308C until the cortisol assay. The DNA content, estimated using the spectrophotometric method by Labarca and Paigen [23] , was used to standardize the results.
Experiment 2: Effect of Indomethacin on HSD11B1 Bioactivity
To confirm that an inhibitor of cyclooxygenase (PTGS), indomethacin, suppresses PG synthesis, stromal cells were treated for 4 h with 10 lM indomethacin (No. I7378; Sigma Aldrich). The concentration of indomethacin was based on a previous study [24] . Stromal cells were treated for 4 h with cortisone (30 nM) or PGF2a (1 lM) in the presence or absence of 10 lM indomethacin (n ¼ 4). At the end of incubation, 500 ll of conditioned media was collected and frozen at À308C until the PGF2a and cortisol assays. The DNA content, estimated using the spectrophotometric method by Labarca and Paigen [23] , was used to standardize the results.
Experiment 3: Effect of PGF2a on HSD11B1 mRNA and Protein Expression
Stromal cells were exposed to cortisone (30 nM) or PGF2a (100 nM to 10 lM) for 4 h and 24 h (n ¼ 4). After incubation, tRNA was extracted for determination of HSD11B1 mRNA expression. For protein analysis, stromal cells were exposed to PGF2a (1 lM) for 4 h and 24 h (n ¼ 4). To examine the dose-dependent effects of PGF2a on HSD11B1 protein expression, stromal cells were exposed to PGF2a (0. 
Experiment 4: Effect of Cycloheximide on the Stimulatory Effects of PGF2a on HSD11B1 Protein Expression
To examine the effect of cycloheximide (CHX, No. C0130; Sigma Aldrich) on the stimulatory effects of PGF2a on HSD11B1 protein expression (n ¼ 4), stromal cells were treated for 24 h with 1 lM PGF2a in the presence or absence of 35 lM CHX according to previous studies [25, 26] . Cultured cells were scraped and placed in ice-cold homogenization buffer (25 mM Tris-HCl, 300 mM sucrose, 2 mM EDTA, Complete, pH 7.4) and then frozen in liquid nitrogen and stored at À808C until HSD11B1 protein analysis by Western blotting.
HSD11B1 Bioactivity
The level of HSD11B reductase bioactivity in endometrial stromal cells was determined by measuring the net conversion rate from cortisone to cortisol as described previously [7] , with some modifications. Basically, media containing cortisone (30 nM) without cells were incubated in the same plate for the blank value and to determine nonspecific interconversion. The specific conversion rate from cortisone to cortisol was calculated, and the blank values (defined as the amount of conversion in the absence of tissue) were subtracted.
PGF2a, PGE2, and Cortisol Determination
The concentrations of PGF2a in the culture medium were determined by enzyme immunoassay (EIA). The PGF2a standard curve ranged from 0.016 to 4 ng/ml, and the median effective dose (ED50) of the assay was 0.25 ng/ml. The intraassay and interassay coefficients of variation were on average 2.8% and 7.7%, respectively. The PGE2 standard curve ranged from 0.039 to 10 ng/ ml, and the ED50 of the assay was 0.625 ng/ml. The intraassay and interassay coefficients of variation were on average 11.33% and 13.29%, respectively. The cross-reactivities of the anti-PGE2 serum, validated by comparing the inhibition of binding of peroxidase-labeled PGE2 with that of antiserum, were as follows: 100% for PGE2, 15% for PGE1, 10% for PGA1, 6.7% for PGB2, 4.6% for PGA2, 2.8% for PGF2a, 0.13% for PGD2, and 0.05% for 15-keto-PGE2. The EIA for cortisol was performed as described previously [7] . The 658 LEE ET AL. standard curve ranged from 0.1 to 400 ng/ml, and the ED50 of the assay was 1.6 ng/ml. The intraassay and interassay coefficients of variation were on average 5.4% and 6.0%, respectively.
Reverse Transcription and Real-Time PCR
Total RNA was extracted from endometrial tissue using Trizol reagent (Invitrogen) according to the manufacturer's directions. One microgram of each tRNA was reverse transcribed using a ThermoScript RT-PCR System (Invitrogen), and 10% of the reaction mixture was used in each PCR using specific primers for HSD11B1 from the bovine sequence. The primers were chosen using Primer3, an online software package (http://primer3.sourceforge.net/).
Gene expression was measured by real-time PCR using the Mx3000P QPCR System (Stratagene, La Jolla, CA) and the QuantiTect SYBR Green PCR system (Qiagen GmbH, Hilden, Germany), starting with 2 ng of reversetranscribed tRNA as described previously [27] . Briefly, glyceraldehyde phosphate dehydrogenase (GAPDH) expression was used as an internal control. For quantification of the mRNA expression levels, the primer length (20 bp) and GC contents of each primer (50%-60%) were selected, and PCR was performed under the following conditions: 958C for 15 min, followed by 55 cycles of 948C for 15 sec, 558C for 20 sec, and 728C for 15 sec. Use of the QuantiTect SYBR Green PCR system at elevated temperatures resulted in reliable and sensitive quantification of the RT-PCR products with high linearity (Pearson product moment correlation coefficient r . 0.99). Sigma Aldrich]) for 1 h at room temperature. The original concentrations of primary antibodies were 400 lg/ml for HSD11B1 and 2 mg/ml for ACTB. After incubation, the membrane pieces were washed three times for 10 min in TBS-T at room temperature and then incubated with secondary antibody to HSD11B1 (1:5000 in TBS-T) (anti-rabbit Ig, horseradish peroxidase [HRP]-linked whole antibody produced in donkey, No. NA934; Amersham Biosciences Corp., Piscataway, NJ) and to ACTB (1:40 000 in TBS-T) (antimouse Ig, HRP-linked whole antibody produced in sheep, No. NA931; Amersham Biosciences Corp.) for 1 h and washed three times in TBS for 10 min at room temperature. The signal was detected using an ECL Western blotting detection system (No. RPN2109; Amersham Biosciences Corp.). The intensity of the immunological reaction in the cells was estimated by measuring the optical density in the defined area by computerized densitometry using NIH Image (National Institutes of Health, Bethesda, MD).
HSD11B1 Protein Analysis
Statistical Analysis
All experimental data are given as the mean 6 SEM of values obtained in 3-4 separate experiments in which each experimental triplicate was performed using stromal cells from a single bovine endometrium. The statistical significance of differences in the bioactivity and mRNA expression of HSD11B1 was assessed by ANOVA, followed by Fisher protected least significant difference procedure (PLSD) as a multiple comparisons test. Statistical significance of differences in HSD11B1 protein expression was assessed using Student t-test.
RESULTS
Preliminary Experiment: Spontaneous PGF2a and PGE2 Release
The accumulated PGF2a and PGE2 concentrations in culture media increased at 12 h of incubation (P , 0.05 for both). These results are shown in Figure 1 , A and B.
Experiment 1: Dose-and Time-Dependent Effects of PGF2a and PGE2 on HSD11B1 Bioactivity
PGF2a increased the net conversion of cortisone to cortisol in endometrial stromal cells in a dose-dependent manner (P , 0.05) (Fig. 2A) . A significant increase in HSD11B1 bioactivity, as determined by the conversion rate of cortisone to cortisol, was detected 4 h after exposure of stromal cells to PGF2a (1 and 10 lM, P , 0.05) (Fig. 2B) . In addition, the timedependent effect of PGF2a on HSD11B1 bioactivity was observed after various periods (0.5-24 h) of incubation with or without PGF2a (1 lM). PGF2a (1 lM) increased the net conversion of cortisone to cortisol in endometrial stromal cells within 4 h of incubation, whereas 12 h of incubation were required to observe an increase in HSD11B1 bioactivity in PGF2a-untreated cells. However, PGE2 had no significant effect on HSD11B1 bioactivity at 4 h or at 24 h (Fig. 2C) . Indomethacin decreased PGF2a production in the stromal cells (P , 0.05) (Fig. 3A) . The bioactivity of HSD11B1 was significantly inhibited by indomethacin (10 lM). PGF2a (1 lM) abolished the inhibitory effect of indomethacin on HSD11B1 bioactivity (P , 0.05) (Fig. 3B ).
Experiment 3: Effect of PGF2a on HSD11B1 mRNA and Protein Expression
PGF2a had no significant effect on the expression of HSD11B1 mRNA at 4 h and 24 h (Fig. 4) . PGF2a (1 lM) significantly increased the expression of HSD11B1 protein at 24 h but not at 4 h. In addition, PGF2a increased the expression of HSD11B1 protein in a dose-dependent manner. The intensities of HSD11B1-specific bands, after normalization to ACTB-specific bands, significantly increased after exposure of endometrial stromal cells to PGF2a for 24 h (P , 0.05) (Figs. 5 and 6 ).
Experiment 4: Effect of CHX on the Stimulatory Effects of PGF2a on HSD11B1 Protein Expression
Cycloheximide alone did not affect HSD11B1 protein expression in endometrial stromal cells, whereas it abolished the stimulatory effects of PGF2a on HSD11B1 protein. The intensities of HSD11B1-specific bands, after normalization to ACTB-specific bands, significantly increased after exposure of endometrial stromal cells to PGF2a for 24 h (P , 0.05) (Fig.  7) .
DISCUSSION
The present study demonstrated that PGF2a stimulates the bioactivity and protein expression of HSD11B1 in cultured   FIG. 2 . Dose-dependent (A) and time-dependent (B) effects of PGF2a on HSD11B1 bioactivity in bovine endometrial stromal cells. HSD11B1 bioactivity was determined using cortisone as substrate. A) Cells were exposed to cortisone (30 nM) alone or in combination with PGF2a (10 nM to 10 lM) for 4 h and 24 h. B) Cells were exposed to cortisone (30 nM) alone or in combination with PGF2a (1 lM) for 0, 0.5, 1, 4, 12, and 24 h. Data are the mean 6 SEM of four separate experiments. Asterisks indicate significant difference (*P , 0.05, **P , 0.01 compared with control [Cont]) as determined by ANOVA, followed by Fisher PLSD as a multiple comparisons test. #P , 0.05 indicates significant stimulation by PGF2a. C) Dose-dependent effects of PGE2 on HSD11B1 bioactivity at 4 h and 24 h in bovine endometrial stromal cells. Data are the mean 6 SEM of four separate experiments.
FIG. 3. Effects of indomethacin (Indo) on PGF2a concentration (A) and
HSD11B1 bioactivity (B) in bovine endometrial stromal cells exposed to Indo (10 lM) for 4 h. Cells were incubated with cortisone (30 nM) in the presence or absence of Indo (10 lM) or PGF2a (1 lM) for 4 h. Different letters and asterisk indicate significant difference (P , 0.05) as determined by ANOVA, followed by Fisher PLSD as a multiple comparisons test. Data are the mean 6 SEM of four separate experiments. Cont, control.
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bovine endometrial stromal cells in a dose-dependent manner. In addition, indomethacin, an inhibitor of PTGS, suppressed the net conversion of cortisone to cortisol. These findings suggest that locally produced endometrial PGF2a increases HSD11B1 protein synthesis and activates HSD11B1.
We previously demonstrated that bovine endometrium expresses HSD11B1 mRNA and converts biologically inactive cortisone into active cortisol [7] . Increased levels of HSD11B1 mRNA and bioactivity were temporally coincident with the increase in the basal release of PGF2a during the estrous cycle [7] [8] [9] . Therefore, we hypothesized that PGs produced by the endometrium locally enhance HSD11B1 actions in endometrial cells in a manner that would increase the local formation of cortisol from cortisone. In the present study, although PGE2 did not significantly affect the bioactivity of HSD11B1, PGF2a increased HSD11B1 bioactivity in a dose-dependent manner and increased the net conversion of cortisone to cortisol in cultured endometrial stromal cells. However, because the concentrations of PGF2a required to stimulate HSD11B1 bioactivity were high (1 and 10 lM), the stimulatory action of PGF2a on HSD11B1 bioactivity may not be triggered unless PGF2a levels reach a certain high level in vivo. The finding that the bioactivity of HSD11B1, as well as the endogenous production of PGF2a (accumulated PGF2a in the culture media), coincidently increased after 12 h of incubation in the stromal cells supports the hypothesis that endogenous PGF2a is involved in the net conversion rate of cortisone to cortisol in endometrial stromal cells. Furthermore, exposure of stromal cells to PGF2a (1 lM) increased the net conversion of cortisone to cortisol in stromal cells within 4 h after treatment. The shorter time required for higher concentration of PGF2a to increase the net conversion of cortisone to cortisol indicates that PGF2a has the ability to increase HSD11B1 bioactivity in stromal cells.
A stimulatory effect of PGF2a on HSD11B1 has also been observed in human placenta [12] . PGF2a increased the local conversion of cortisone to cortisol by increasing HSD11B1. In addition, GC stimulated PG synthesis in fetal membranes of human [29, 30] and sheep [31] . These findings imply the 
EFFECTS OF PGF2a ON HSD11B1
presence of a positive feedback loop between local PG and cortisol synthesis during late pregnancy and labor [12, 13] . Our preliminary study using uteri of cyclic and early pregnant cows showed higher expression of HSD11B1 protein in endometrium on Days 16-18 of pregnancy compared with that on Days 16-18 of the estrous cycle. Interferon-s stimulated the production of cortisol in endometrial cells by increasing the protein and enzymatic activity of HSD11B1 (Lee, Skarzynski, and Okuda; unpublished results), suggesting that GC has physiological roles in bovine endometrium during early pregnancy. In contrast, we demonstrated that cortisol suppresses luteolytic PGF2a production in nonpregnant bovine endometrium [7] , and in the present study we demonstrated that PGF2a stimulates cortisol production by increasing HSD11B1 activation. These results suggest the presence of a negative feedback loop between local PGF2a and cortisol synthesis in nonpregnant bovine endometrium. Because the functional interactions between the GC and PG systems seem to differ between pregnant and nonpregnant endometrium [7, 12, 13] , further studies are required to demonstrate the different mechanisms regulating these interactions in pregnant bovine endometrium.
Indomethacin, an inhibitor of PTGS, significantly inhibits PG production in the bovine endometrial cells [21, 32] . In the present study, indomethacin inhibited HSD11B1 bioactivity and PGF2a production in endometrial stromal cells. Because the inhibitory effect of indomethacin on HSD11B1 bioactivity was compensated by cotreatment with PGF2a, the suppressive effect of indomethacin on HSD11B1 bioactivity seems to be due to the decrease in endogenous PG production. These findings suggest that PGF2a exerts a direct stimulatory action on HSD11B1 bioactivity.
Cytokines and PGs are implicated in reproductive physiology by controlling uterine events such as menstruation, implantation, and parturition [33] . Extremely high levels of PGF2a have also been known to be associated with inflammatory processes of bovine endometrium (endometritis) [34] and endometrial degeneration (endometriosis) [35] and are believed to cause premature luteolysis and early embryonic loss [36] . In contrast, GC inhibits inflammatory processes mediated by cytokines [37] [38] [39] [40] [41] and suppresses PG production in nonpregnant bovine endometrium [7, 42] . Interleukin (IL)-1b and TNFa stimulate HSD11B1 mRNA expression and enzyme activity via increasing PG production in rat glomerular mesangial cells [43] . A recent study [44] using human granulosa-lutein cells suggests that the stimulatory effect of IL-1b on HSD11B1 is mediated by PGs. In the present study, PGF2a directly stimulated HSD11B1 in bovine endometrial stromal cells. Therefore, the activation of 11HSD1 by PGF2a may be physiologically relevant for protecting the endometrium against inflammatory and degenerative processes by preventing excessive PGF2a production. Because PGE2 did not significantly affect the bioactivity of HSD11B1, the effects of PGE2 on HSD11B1 mRNA and protein expressions were not analyzed.
Gene expression can be regulated at the transcriptional, posttranscriptional (altering mRNA stability), translation (affecting protein synthesis), and posttranslation (altering protein processing, modification, or degradation) levels [45] . In the present study, because PGF2a induced an increase in HSD11B1 protein but did not affect HSD11B1 mRNA 662 expression, the modulation of PGF2a on HSD11B1 expression may take place mainly at the posttranscriptional level. Cycloheximide, a general translational inhibitor [46, 47] , inhibited the expression of HSD11B1 protein and abolished the stimulatory effect of PGF2a on HSD11B1 protein expression in cultured bovine endometrial stromal cells. These results indicate that PGF2a increases HSD11B1 protein expression via stimulation of a posttranscriptional process rather than a transcriptional mechanism.
This study demonstrated that PGF2a increases HSD11B1 bioactivity and protein expression by stimulating a posttranscriptional mechanism in cultured bovine endometrial stromal cells. Our findings suggest that cortisol has a physiologically relevant role in preventing excessive uterine PG production in bovine endometrium.
